ebomi
Colour theme
Sign in
Insider · CIK 0001579824

Baum Charles M

CIK 0001579824 Name as filed on the most recent filing

Filed as Baum Charles M (19)

50 transaction lines · from 19 filings · filed 2013-11-26 to 2023-01-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

50 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-01-04 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,648 disposed 46.60 169,996.80 Form 4, filing 0001214659-23-000290
2022-12-21 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 9,092 disposed 40.42 367,468.64 Form 4, filing 0001214659-22-015200
2022-11-28 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 69,256 disposed 100.00 6,925,600.00 Form 4, filing 0001214659-22-014229
2022-01-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 2,517 disposed 120.48 303,253.45 Form 4, filing 0001214659-22-000856
2022-01-04 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,045 disposed 147.73 597,567.85 Form 4, filing 0001214659-22-000419
2022-01-04 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 69 disposed 149.08 10,286.86 Form 4, filing 0001214659-22-000419
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 21,509 disposed 132.49 2,849,720.96 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 9,200 disposed 131.61 1,210,803.72 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 6,558 disposed 135.64 889,538.92 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,900 disposed 133.27 519,744.42 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,842 disposed 134.57 517,023.32 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,210 disposed 136.66 165,360.90 Form 4, filing 0001214659-21-012712
2021-12-03 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 985 disposed 137.56 135,495.22 Form 4, filing 0001214659-21-012712
2021-06-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 20,823 disposed 166.07 3,457,986.07 Form 4, filing 0001214659-21-006762
2021-06-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 13,338 disposed 164.90 2,199,498.89 Form 4, filing 0001214659-21-006762
2021-06-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,816 disposed 164.07 790,181.83 Form 4, filing 0001214659-21-006762
2021-06-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,023 disposed 166.73 170,565.81 Form 4, filing 0001214659-21-006762
2021-01-06 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,421 disposed 210.28 929,647.88 Form 4, filing 0001214659-21-000332
2021-01-06 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 90 disposed 215.76 19,418.34 Form 4, filing 0001214659-21-000332
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 22,932 disposed 234.26 5,371,997.58 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 9,888 disposed 233.43 2,308,144.96 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,250 disposed 236.17 1,003,731.85 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 2,020 disposed 237.26 479,255.10 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 493 disposed 235.20 115,955.67 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 317 disposed 240.23 76,152.91 Form 4, filing 0001214659-20-010598
2020-12-18 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 100 disposed 238.76 23,875.50 Form 4, filing 0001214659-20-010598
2020-04-17 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 25,184 disposed 90.41 2,276,958.47 Form 4, filing 0001214659-20-003519
2020-04-17 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 10,526 disposed 89.59 943,058.02 Form 4, filing 0001214659-20-003519
2020-04-17 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,290 disposed 91.63 393,092.27 Form 4, filing 0001214659-20-003519
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 28,446 disposed 85.89 2,443,093.24 Form 4, filing 0001214659-19-005436
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 11,843 disposed 85.03 1,006,996.08 Form 4, filing 0001214659-19-005436
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4,544 disposed 88.24 400,967.10 Form 4, filing 0001214659-19-005436
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 3,619 disposed 86.58 313,325.78 Form 4, filing 0001214659-19-005436
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,736 disposed 91.12 158,176.68 Form 4, filing 0001214659-19-005436
2019-08-22 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,622 disposed 89.24 144,752.79 Form 4, filing 0001214659-19-005436
2019-02-25 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 25,722 disposed 75.17 1,933,553.61 Form 4, filing 0001214659-19-001618
2019-02-25 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 18,235 disposed 75.77 1,381,642.24 Form 4, filing 0001214659-19-001618
2019-02-25 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 5,687 disposed 76.75 436,502.84 Form 4, filing 0001214659-19-001618
2019-02-25 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 2,066 disposed 77.96 161,063.91 Form 4, filing 0001214659-19-001618
2019-02-25 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 100 disposed 79.09 7,909.00 Form 4, filing 0001214659-19-001618
2018-08-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 32,514 disposed 57.86 1,881,325.07 Form 4, filing 0001214659-18-005702
2018-08-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 17,434 disposed 56.88 991,729.60 Form 4, filing 0001214659-18-005702
2018-08-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1,862 disposed 58.40 108,733.72 Form 4, filing 0001214659-18-005702
2018-02-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 40,748 disposed 27.89 1,136,551.37 Form 4, filing 0001214659-18-001631
2018-02-23 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 11,062 disposed 28.56 315,906.38 Form 4, filing 0001214659-18-001631
2018-02-09 Array Biopharma Inc
ARRY 		S, Open-market sale 50,000 disposed 16.90 845,000.00 Form 4, filing 0001562180-18-000727
2017-03-28 Array Biopharma Inc
ARRY 		S, Open-market sale 25,000 disposed 9.27 231,750.00 Form 4, filing 0001562180-17-001360
2016-06-14 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 20,000 acquired 7.05 141,070.00 Form 4, filing 0001190725-16-000428
2015-05-08 Array Biopharma Inc
ARRY 		S, Open-market sale 25,000 disposed 7.38 184,482.50 Form 4, filing 0001127602-15-017039
2013-11-26 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 5,000 acquired 16.96 84,819.00 Form 4, filing 0001209191-13-054179

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 48
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BAUM CHARLES M, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001579824

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.